Campaigners have begun a legal process intended to suspend a clinical trial of puberty blockers on the grounds that the research could prove harmful to the children taking part.
The study was commissioned in response to last year’s review of gender identity services by Dr Hilary Cass, which found that gender medicine was an “area of remarkably weak evidence” and “built on shaky foundations”.
